263_16042021_S42
human gut metagenome
ALT
15.333333333333336
AST
31.66666666666667
C-reactive protein
276.49333333333334
D-dimer
7650.0
INSDC center name
Malopolska Centre of Biotechnology
LDH (L)
480.0
Submitter Id
263_16042021_S42
adapters
AGATCGGAAGAGCACACGTCTGAACTCCAGTCA, AGATCGGAAGAGCGTCGTGTAGGGAAAGAGTGT
alcohol consumption frequency
3-5 times a month
allergy
no
antibiotic dose
2000
antibiotic treatment during hospitalization
yes
antibiotics before hospital
one week
broad-scale environmental context
material anatomical entity
collection date
2021-04-16
death
yes
diabetes
yes
diabetes type
type II diabetes
environmental medium
feces
ethnicity
White
ferritin
693.0
geographic location (country and/or sea)
Poland
geographic location (latitude)
52.24
geographic location (longitude)
21.02
hospital
PUM
host age
63
host body product
stool
host body site
intestine
host body-mass index
31.6
host height
167
host sex
female
host subject id
263
hypertension
yes
icu
no
interleukin-6
113.0
local environmental context
organism substance
location of the tumour
large intestine
medications dose
100mg, 10mg, 50mg, 75mg, 1000mg, 18j-16j, 813mg
nationality
Polish
number of ciggaretes per day
not provided
other medical conditions
yes
other medications
yes
project name
Gut Microbiome Dynamics and Predictive Value in Hospitalized COVID-19 Patients: A Comparative Analysis of Shallow and Deep Shotgun Sequencing
sample human DNA contamination
0.1
sample name
263_16042021_S42
sample storage temperature
-20
scientific_name
human gut metagenome
seasonal allergy
no
sequencing method
MiSeq
smoker
ciggaretes
smoking frequency
everyday
smoking habit duration
50.0
subject type
patient (case)
tumour
no